Metastatic breast cancer cells in the bone marrow microenvironment: Novel insights into oncoprotection

Oncology Reviews

Volumn 5, Issue 2, 2011, Pages 93-102

  Patel, Shyam A ^a,b   Dave, Meneka A ^a   Murthy, Raghav G ^a   Helmy, Karim Y ^a,b   Rameshwar, Pranela ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b The State University of New Jersey   (United States)

Author keywords

Cancer stem cell; Metastasis; Microenvironment; Oncoprotection

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; HERBACEOUS AGENT; KLF 4; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY EPITHELIAL CELL ADHESION MOLECULE; ONCOSTATIN M; PERIFOSINE; PHOSPHATIDYL INOSITOL ETHER LIPID DERIVATIVE; PROGESTERONE RECEPTOR; RAPAMYCIN; RETINOIC ACID; SALVIANOLIC ACID; SILIBININ; UNCLASSIFIED DRUG; WITHAFERIN A;

BONE MARROW; BONE MARROW METASTASIS; BREAST CANCER; CANCER CELL CULTURE; CANCER STEM CELL; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FIBROBLAST; HUMAN; IMMUNE SYSTEM; MESENCHYMAL STEM CELL; METASTASIS; MYOFIBROBLAST; ONCOLYTIC VIROTHERAPY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 79960470354     PISSN: 19705557     EISSN: 19705565     Source Type: Journal    
DOI: 10.1007/s12156-010-0071-y     Document Type: Review

References (71)

1. RD Baynes RD Dansey JL Klein, et al. 2001 High-dose chemotherapy and hematopoietic stem cell transplantation for breast cancer: past or future? Semin Oncol 28 377 388 11498831 10.1016/S0093-7754(01)90131-9 1:CAS:528: DC%2BD3MXms1Wju7c%3D (Pubitemid 32768579)
2. B Weigelt FC Geyer JS Reis-Filho 2010 Histological types of breast cancer: how special are they? Mol Oncol 4 3 192 208 20452298 10.1016/j.molonc.2010.04.004 1:CAS:528:DC%2BC3cXhtVGlsLvP
3. ML Gatza JE Lucas WT Barry, et al. 2010 A pathway-based classification of human breast cancer Proc Natl Acad Sci USA 107 6994 6999 20335537 10.1073/pnas.0912708107 1:CAS:528:DC%2BC3cXltFSjtr8%3D
4. J de Ronde L Wessels J Wesseling 2010 Molecular subtyping of breast cancer: ready to use? Lancet Oncol 11 306 307 20359657 10.1016/S1470-2045(10) 70036-X
5. AI Khramtsov GF Khramtsova M Tretiakova, et al. 2010 Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome Am J Pathol 176 6 2911 2920 20395444 10.2353/ajpath.2010.091125
6. M Riester C Stephan-Otto Attolini RJ Downey, et al. 2010 A differentiation-based phylogeny of cancer subtypes PLoS Comput Biol 6 5 e1000777 20463876 10.1371/journal.pcbi.1000777
7. RC Millikan B Newman CK Tse, et al. 2008 Epidemiology of basal-like breast cancer Breast Cancer Res Treat 109 123 139 17578664 10.1007/s10549-007- 9632-6 (Pubitemid 351538762)
8. MJ Kim JY Ro SH Ahn, et al. 2006 Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes Hum Pathol 37 1217 1226 16938528 10.1016/j.humpath.2006.04.015 1:CAS:528:DC%2BD28XovVWrt7k%3D (Pubitemid 44286991)
9. Myal Y, Leygue E, Blanchard AA (2010) Claudin 1 in breast tumorigenesis: revelation of a possible novel "claudin high" subset of breast cancers. J Biomed Biotechnol 2010:956897
10. P Tai E Yu K Joseph 2010 Prognostic significance of number of positive nodes: a long-term study of one to two nodes versus three nodes in breast cancer patients Int J Radiat Oncol Biol Phys 77 180 187 20394852 10.1016/j.iJr.obp. 2009.04.073
11. CL Chaffer EW Thompson ED Williams 2007 Mesenchymal to epithelial transition in development and disease Cells Tissues Organs 185 7 19 17587803 10.1159/000101298 (Pubitemid 46956838)
12. NJ Godde RC Galea IA Elsum, et al. 2010 Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions J Mammary Gland Biol Neoplasia 15 2 149 168 20461450 10.1007/s10911-010-9180-2
13. Y Takeyama M Sato M Horio, et al. 2010 Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage- independent cell growth of lung cancer cells Cancer Lett 296 2 216 224 20452118 10.1016/j.canlet.2010.04.008 1:CAS:528:DC%2BC3cXpsFOqurk%3D
14. M Dohadwala G Wang E Heinrich, et al. 2010 The role of ZEB1 in the inflammation-induced promotion of EMT in HNSCC Otolaryngol Head Neck Surg 142 753 759 20416468 10.1016/j.otohns.2010.01.034
15. MA Taylor JG Parvani WP Schiemann 2010 The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells J Mammary Gland Biol Neoplasia 15 2 169 190 20467795 10.1007/s10911-010-9181-1
16. G Lahat QS Zhu KL Huang, et al. 2010 Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies PLoS One 5 4 e10105 20419128 10.1371/journal.pone.0010105
17. S Ohashi M Natsuizaka GS Wong, et al. 2010 Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors Cancer Res 70 4174 4184 20424117 10.1158/0008-5472.CAN-09-4614 1:CAS:528: DC%2BC3cXlvFyqsb8%3D
18. G Berx F van Roy 2009 Involvement of members of the cadherin superfamily in cancer Cold Spring Harb Perspect Biol 1 6 a003129 20457567 10.1101/cshperspect.a003129
19. He H, Davidson AJ, Wu D et al (2010) Phorbol ester phorbol-12-myristate- 13-acetate induces epithelial to mesenchymal transition in human prostate cancer ARCaP(E) cells. Prostate (in press)
20. QL Wang YY Tao JL Yuan, et al. 2010 Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-beta1 signal transduction pathway in vivo and in vitro BMC Cell Biol 11 31 20441599 10.1186/1471-2121-11- 31
21. P Bargagna-Mohan A Hamza YE Kim, et al. 2007 The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin Chem Biol 4 623 634 10.1016/j.chembiol.2007.04.010 (Pubitemid 46920982)
22. JL Yori E Johnson G Zhou, et al. 2010 Kruppel-like factor 4 (KLF4) inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression J Biol Chem 285 22 16854 16863 20356845 10.1074/jbc.M110.114546 1:CAS:528:DC%2BC3cXmtlygtrc%3D
23. K Wu J Zeng L Li J Fan D Zhang Y Xue G Zhu L Yang X Wang D He 2010 Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors Oncol Rep 23 1545 1552 20428808 10.3892/or-00000797 1:CAS:528:DC%2BC3cXmvFyqsbk%3D
24. KO Hong JH Kim JS Hong, et al. 2009 Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells J Exp Clin Cancer Res 28 28 19243631 10.1186/1756-9966-28-28
25. I Haviv K Polyak W Qiu, et al. 2009 Origin of carcinoma associated fibroblasts Cell Cycle 8 589 595 19182519 10.4161/cc.8.4.7669 1:CAS:528:DC%2BD1MXlvFWjtLg%3D
26. JA Potian H Aviv NM Ponzio, et al. 2003 Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens J Immunol 171 3426 3434 14500637 1:CAS:528:DC%2BD3sXnvFSrtrs%3D (Pubitemid 37254543)
27. M Di Ianni B Del Papa M De Ioanni, et al. 2008 Mesenchymal cells recruit and regulate T regulatory cells Exp Hematol 36 309 318 18279718 10.1016/j.exphem.2007.11.007 1:CAS:528:DC%2BD1cXitVGls7o%3D (Pubitemid 351221170)
28. F Casiraghi N Azzollini P Cassis, et al. 2008 Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells J Immunol 181 3933 3946 18768848 1:CAS:528:DC%2BD1cXhtVKntLnI
29. Q Zhang S Shi Y Liu, et al. 2009 Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis J Immunol 183 7787 7798 19923445 10.4049/jimmunol.0902318 1:CAS:528:DC%2BD1MXhsFCkt7vP
30. MA Gonzalez E Gonzalez-Rey L Rico, et al. 2009 Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells Arthritis Rheum 60 1006 1019 19333946 10.1002/art.24405 1:CAS:528:DC%2BD1MXltFenu7Y%3D
31. AM Madec R Mallone G Afonso, et al. 2009 Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells Diabetologia 52 1391 1399 19421731 10.1007/s00125-009-1374-z 1:STN:280:DC%2BD1Mzos1Wktw%3D%3D
32. SA Patel JR. Meyer SJ Greco, et al. 2010 Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta J Immunol 184 10 5885 5894 20382885 10.4049/jimmunol. 0903143 1:CAS:528:DC%2BC3cXls1Wit7s%3D
33. YA Yang O Dukhanina B Tang, et al. 2002 Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects J Clin Invest 109 1607 1615 12070308 1:CAS:528:DC%2BD38Xks12ltbo%3D (Pubitemid 34663523)
34. B Tang M Vu T Booker, et al. 2003 TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression J Clin Invest 112 112 1116
35. Z Selmani A Naji I Zidi, et al. 2008 Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells Stem Cells 26 212 222 17932417 10.1634/stemcells.2007-0554 1:CAS:528: DC%2BD1cXhvVCktb0%3D
36. S Paget 1889 The distributions of secondary growths in cancer of the breast Lancet 1 571 573 10.1016/S0140-6736(00)49915-0
37. PJ Mishra PJ Mishra R Humeniuk, et al. 2008 Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells Cancer Res 68 4331 4339 18519693 10.1158/0008-5472.CAN-08-0943 1:CAS:528:DC%2BD1cXmsFKmurg%3D
38. ES Jeon HJ Moon MJ Lee, et al. 2008 Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells Stem Cells 26 789 797 18065393 10.1634/stemcells.2007-0742 1:CAS:528:DC%2BD1cXltVKitb8%3D
39. M Bauer G Su C Casper, et al. 2010 Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast Oncogene 29 1732 1740 20062080 10.1038/onc.2009.463 1:CAS:528:DC%2BC3cXjsVemug%3D%3D
40. M Sonnenberg H van der Kuip S Haubeis, et al. 2008 Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast BMC Cancer 8 364 19077243 10.1186/1471-2407-8-364
41. G Su SA Blaine D Qiao, et al. 2008 Membrane type 1 matrix metalloproteinase-mediated stromal syndecan-1 shedding stimulates breast carcinoma cell proliferation Cancer Res 68 9558 9565 19010933 10.1158/0008-5472.CAN-08-1645 1:CAS:528:DC%2BD1cXhtlOmt7nF
42. AF Olumi GD Grossfeld SW Hayward, et al. 1999 Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium Cancer Res 59 5002 5011 10519415 1:CAS:528:DyaK1MXmslWktbc%3D (Pubitemid 29472907)
43. AE Karnoub AB Dash AP Vo, et al. 2007 Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Nature 449 557 563 17914389 10.1038/nature06188 1:CAS:528:DC%2BD2sXhtFagt7fI (Pubitemid 47525152)
44. VN Lama SH Phan 2006 The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond Proc Am Thorac Soc 3 373 376 16738203 10.1513/pats.200512-133TK 1:CAS:528:DC%2BD28XmtVOktrw%3D (Pubitemid 43845415)
45. AC LaRue M Masuya Y Ebihara, et al. 2006 Hematopoietic origins of fibroblasts: I. In vivo studies of fibroblasts associated with solid tumors Exp Hematol 34 208 218 16459189 10.1016/j.exphem.2005.10.009 1:CAS:528: DC%2BD28XhtFWhtLo%3D (Pubitemid 43184326)
46. D Bonnet JE Dick 1997 Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med 3 730 737 9212098 10.1038/nm0797-730 1:CAS:528:DyaK2sXkt1GrtLY%3D (Pubitemid 27298715)
47. T Reya SJ Morrison MF Clarke, et al. 2001 Stem cells, cancer, and cancer stem cells Nature 414 105 111 11689955 10.1038/35102167 1:CAS:528: DC%2BD3MXot1ahs7c%3D (Pubitemid 33041634)
48. JU Marquardt SS Thorgeirsson 2010 Stem cells in hepatocarcinogenesis: evidence from genomic data Semin Liver Dis 30 26 34 20175031 10.1055/s-0030-1247130 1:CAS:528:DC%2BC3cXjvFCqtbs%3D
49. S Hubbard C Gargett 2010 A cancer stem cell origin for human endometrial carcinoma? Reproduction 140 1 23 32 20089663 10.1530/REP-09-0411 1:CAS:528:DC%2BC3cXhtVWlsrfL
50. K Kohga T Tatsumi T Takehara, et al. 2010 Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma J Hepatol 52 6 872 879 20395004 10.1016/j.jhep.2009.12.030 1:CAS:528:DC%2BC3cXmsVejurc%3D
51. H Yasuda K Tanaka S Saigusa, et al. 2009 Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer Oncol Rep 22 709 717 19724847 1:CAS:528:DC%2BD1MXht1WqsLzO
52. CE Brown R Starr C Martinez, et al. 2009 Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells Cancer Res 69 8886 8893 19903840 10.1158/0008-5472.CAN-09-2687 1:CAS:528:DC%2BD1MXhsV2itLvN
53. KK Youssef A Van Keymeulen G Lapouge, et al. 2010 Identification of the cell lineage at the origin of basal cell carcinoma Nat Cell Biol 12 299 305 20154679 1:CAS:528:DC%2BC3cXisFems74%3D
54. B Groner V Vafaizadeh B Brill, et al. 2010 Stem cells of the breast and cancer therapy Womens Health 6 205 219
55. D Giuffrida I Rogers 2010 Targeting cancer stem cell lines as a new treatment of human cancer Recent Pat Anticancer Drug Discov 5 3 205 218 20402651 10.2174/157489210791760535 1:CAS:528:DC%2BC3cXhsVSrsr7J
56. M Arifin K Tanimoto AC Putra, et al. 2010 Carcinogenesis and cellular immortalization without persistent inactivation of p16/Rb pathway in lung cancer Int J Oncol 36 1217 1227 20372796 1:CAS:528:DC%2BC3cXmsVSqtb4%3D
57. N Ahmed K Abubaker J Findlay, et al. 2010 Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer Curr Cancer Drug Targets 10 268 278 20370691 10.2174/156800910791190175 1:CAS:528:DC%2BC3cXns1SnsbY%3D
58. J Luo X Yin T Ma, et al. 2010 Stem cells in normal mammary gland and breast cancer Am J Med Sci 339 366 370 20224316
59. A Castellanos C Vicente-Dueñas E Campos-Sánchez, et al. 2010 Cancer as a reprogramming-like disease: Implications in tumor development and treatment Semin Cancer Biol 20 2 93 97 20188174 10.1016/j.semcancer.2010.02.001 1:CAS:528:DC%2BC3cXnvVyhu74%3D
60. JE Shabason K Camphausen 2010 Cancer stem cells as a prognostic indicator for glioblastoma multiforme Biomark Med 4 127 128 20387308 10.2217/bmm.09.90
61. B ten Cate M de Bruyn Y Wei, et al. 2010 Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology Curr Drug Targets 11 95 110 20017722 10.2174/138945010790031063 1:CAS:528:DC%2BC3cXisVCitrs%3D
62. LA Carey CM Perou CA Livasy, et al. 2006 Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2492 2502 16757721 10.1001/jama.295.21.2492 1:CAS:528:DC%2BD28XlsV2rtLw%3D (Pubitemid 43854964)
63. M Eriksson K Guse G Bauerschmitz, et al. 2007 Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/low cells Mol Ther 15 2088 2093 17848962 10.1038/sj.mt.6300300 1:CAS:528:DC%2BD2sXhtlalsrrN (Pubitemid 350148923)
64. M Redova P Chlapek T Loja, et al. 2010 Influence of LOX/COX inhibitors on cell differentiation induced by all-trans retinoic acid in neuroblastoma cell lines Int J Mol Med 25 271 280 20043138 1:CAS:528:DC%2BC3cXitF2ht7Y%3D
65. T Yamashita M Honda K Nio, et al. 2010 Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation Cancer Res 70 11 4687 4697 20484035 10.1158/0008-5472.CAN-09-4210 1:CAS:528:DC%2BC3cXmslWgtb0%3D
66. AV Salnikov A Groth A Apel, et al. 2009 Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma J Cell Mol Med 13 4023 4033 20196789 10.1111/j.1582-4934.2009.00723.x
67. PL Tazzari G Tabellini F Ricci, et al. 2008 Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cells Cancer Res 68 9394 9403 19010914 10.1158/0008-5472. CAN-08-2815 1:CAS:528:DC%2BD1cXhtlOmt7vF
68. M Zhang RL Atkinson JM Rosen 2010 Selective targeting of radiation-resistant tumor-initiating cells Proc Natl Acad Sci USA 107 3522 3527 20133717 10.1073/pnas.0910179107 1:CAS:528:DC%2BC3cXjtFymu7s%3D
69. K Grymula M Tarnowski M Wysoczynski, et al. 2010 Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas Int J Cancer 127 11 2554 2568 20162608 10.1002/ijc.25245 1:CAS:528:DC%2BC3cXhsVGhtrfL
70. F Dillmann MR Veldwijk S Laufs, et al. 2009 Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib Leuk Lymphoma 50 1676 1686 19657955 10.1080/10428190903150847 1:CAS:528:DC%2BD1MXhsVCksL%2FP
71. EI Galanzha JW Kim VP Zharov 2009 Nanotechnology-based molecular photoacoustic and photothermal flow cytometry platform for in vivo detection and killing of circulating cancer stem cells J Biophotonics 2 725 735 19957272 10.1002/jbio.200910078 1:CAS:528:DC%2BC3cXhtVWis70%3D